Insufficient scRNA-seq data for expression of IL22RA1 at single-cell level.
Insufficient scRNA-seq data for expression of IL22RA1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 14715.98 | 328 / 328 | 90% | 38.58 | 161 / 178 |
liver | 78% | 434.67 | 177 / 226 | 79% | 17.44 | 321 / 406 |
intestine | 40% | 862.14 | 384 / 966 | 97% | 55.02 | 510 / 527 |
esophagus | 39% | 765.82 | 557 / 1445 | 96% | 30.70 | 175 / 183 |
stomach | 16% | 72.98 | 57 / 359 | 93% | 49.36 | 267 / 286 |
kidney | 30% | 160.33 | 27 / 89 | 63% | 6.75 | 567 / 901 |
tonsil | 0% | 0 | 0 / 0 | 89% | 15.36 | 40 / 45 |
skin | 72% | 3424.89 | 1296 / 1809 | 14% | 1.76 | 66 / 472 |
uterus | 1% | 19.05 | 2 / 170 | 71% | 11.29 | 324 / 459 |
bladder | 0% | 0 | 0 / 21 | 66% | 18.28 | 333 / 504 |
lung | 11% | 49.90 | 62 / 578 | 55% | 9.10 | 634 / 1155 |
thymus | 21% | 94.58 | 140 / 653 | 38% | 4.65 | 231 / 605 |
ovary | 0% | 0 | 0 / 180 | 29% | 2.95 | 123 / 430 |
lymph node | 0% | 0 | 0 / 0 | 17% | 1.58 | 5 / 29 |
adrenal gland | 0% | 1.21 | 1 / 258 | 16% | 3.33 | 37 / 230 |
breast | 8% | 31.40 | 35 / 459 | 8% | 0.54 | 86 / 1118 |
prostate | 3% | 11.08 | 7 / 245 | 2% | 0.15 | 11 / 502 |
adipose | 4% | 22.72 | 51 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 4.14 | 4 / 1335 | 0% | 0 | 0 / 0 |
muscle | 0% | 1.24 | 2 / 803 | 0% | 0 | 0 / 0 |
brain | 0% | 0.12 | 1 / 2642 | 0% | 0 | 0 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0050829 | Biological process | defense response to Gram-negative bacterium |
GO_0019221 | Biological process | cytokine-mediated signaling pathway |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0008150 | Biological process | biological_process |
GO_0140865 | Biological process | interleukin-22-mediated signaling pathway |
GO_0005886 | Cellular component | plasma membrane |
GO_0042018 | Molecular function | interleukin-22 receptor activity |
GO_0004904 | Molecular function | interferon receptor activity |
GO_0042015 | Molecular function | interleukin-20 binding |
GO_0005515 | Molecular function | protein binding |
GO_0004896 | Molecular function | cytokine receptor activity |
Gene name | IL22RA1 |
Protein name | Interleukin-22 receptor subunit alpha-1 (IL-22 receptor subunit alpha-1) (IL-22R-alpha-1) (IL-22RA1) (Cytokine receptor class-II member 9) (Cytokine receptor family 2 member 9) (CRF2-9) (ZcytoR11) |
Synonyms | IL22R |
Description | FUNCTION: Component of the receptor for IL20, IL22 and IL24. Component of IL22 receptor formed by IL22RA1 and IL10RB enabling IL22 signaling via JAK/STAT pathways. IL22 also induces activation of MAPK1/MAPK3 and Akt kinases pathways. Component of one of the receptor for IL20 and IL24 formed by IL22RA1 and IL20RB also signaling through STATs activation. Mediates IL24 antiangiogenic activity as well as IL24 inhibitory effect on endothelial cell tube formation and differentiation. . |
Accessions | ENST00000270800.2 Q8N6P7 |